Your browser doesn't support javascript.
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.
Streeck, Hendrik; Schulte, Bianca; Kümmerer, Beate M; Richter, Enrico; Höller, Tobias; Fuhrmann, Christine; Bartok, Eva; Dolscheid-Pommerich, Ramona; Berger, Moritz; Wessendorf, Lukas; Eschbach-Bludau, Monika; Kellings, Angelika; Schwaiger, Astrid; Coenen, Martin; Hoffmann, Per; Stoffel-Wagner, Birgit; Nöthen, Markus M; Eis-Hübinger, Anna M; Exner, Martin; Schmithausen, Ricarda Maria; Schmid, Matthias; Hartmann, Gunther.
  • Streeck H; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany. hendrik.streeck@ukbonn.de.
  • Schulte B; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany. hendrik.streeck@ukbonn.de.
  • Kümmerer BM; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
  • Richter E; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Höller T; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
  • Fuhrmann C; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Bartok E; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
  • Dolscheid-Pommerich R; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Berger M; Clinical Study Core Unit, Study Center Bonn (SZB), University Hospital, University of Bonn, Bonn, Germany.
  • Wessendorf L; Clinical Study Core Unit, Study Center Bonn (SZB), University Hospital, University of Bonn, Bonn, Germany.
  • Eschbach-Bludau M; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Kellings A; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.
  • Schwaiger A; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Coenen M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.
  • Hoffmann P; Institute for Medical Biometry, Informatics and Epidemiology, University Hospital, University of Bonn, Bonn, Germany.
  • Stoffel-Wagner B; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
  • Nöthen MM; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Eis-Hübinger AM; Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
  • Exner M; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Braunschweig, Germany.
  • Schmithausen RM; Clinical Study Core Unit, Study Center Bonn (SZB), University Hospital, University of Bonn, Bonn, Germany.
  • Schmid M; Biobank Core Unit, University Hospital, University of Bonn, Bonn, Germany.
  • Hartmann G; Clinical Study Core Unit, Study Center Bonn (SZB), University Hospital, University of Bonn, Bonn, Germany.
Nat Commun ; 11(1): 5829, 2020 11 17.
Article in English | MEDLINE | ID: covidwho-933682
ABSTRACT
A SARS-CoV2 super-spreading event occurred during carnival in a small town in Germany. Due to the rapidly imposed lockdown and its relatively closed community, this town was seen as an ideal model to investigate the infection fatality rate (IFR). Here, a 7-day seroepidemiological observational study was performed to collect information and biomaterials from a random, household-based study population. The number of infections was determined by IgG analyses and PCR testing. We found that of the 919 individuals with evaluable infection status, 15.5% (95% CI[12.3%; 19.0%]) were infected. This is a fivefold higher rate than the reported cases for this community (3.1%). 22.2% of all infected individuals were asymptomatic. The estimated IFR was 0.36% (95% CI[0.29%; 0.45%]) for the community and 0.35% [0.28%; 0.45%] when age-standardized to the population of the community. Participation in carnival increased both infection rate (21.3% versus 9.5%, p < 0.001) and number of symptoms (estimated relative mean increase 1.6, p = 0.007). While the infection rate here is not representative for Germany, the IFR is useful to estimate the consequences of the pandemic in places with similar healthcare systems and population characteristics. Whether the super-spreading event not only increases the infection rate but also affects the IFR requires further investigation.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-19509-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2020 Document Type: Article Affiliation country: S41467-020-19509-y